Phase II study granted authorization in Europe

Authorization granted for a phase 2 clinical trial that aims to evaluate the technology developed by Hemerion. This study sponsored by Lille University Hopital (France) is multicentric with additional investigative center in Brussels (Erasme Hospital – Belgium).